<?xml version="1.0" encoding="UTF-8"?>
<results title="test_trace">
 <result pre="viral restriction [16,17,18,19,20]. Nucleoside analogues are commonly used in the" exact="treatment" post="of viral infections and cancer [21]. Following phosphorylation by"/>
 <result pre="(AML) and SAMHD1 expression levels were negatively correlated with Ara-C" exact="treatment" post="success in individuals with AML [27,29,32]. Here, we evaluated"/>
 <result pre="differentiation initiates MDM proliferation accompanied by SAMHD1 phosphorylation. Thus, HIV-1" exact="infection" post="of MDM provides an excellent model in which to"/>
 <result pre="activity of a panel of antimetabolite drugs used in cancer" exact="treatment" post="was evaluated in MDMs in the presence or absence"/>
 <result pre="subsequently reducing the intracellular dNTP pool. Interestingly, pemetrexed and fluorouracil" exact="treatment" post="resulted in different effects, i.e., while fluorouracil acts similarly"/>
 <result pre="inhibition of nucleotide synthesis has been commonly used in the" exact="treatment" post="of cancer, infectious diseases and immune-mediated diseases [34]. By"/>
 <result pre="cancers like nelarabine for T-lymphoblastic lymphoma, cladribine used in the" exact="treatment" post="of hairy cell leukemia and B-cell chronic lymphocytic leukemia,"/>
 <result pre="leukemia and B-cell chronic lymphocytic leukemia, and approved for the" exact="treatment" post="of relapsing-remitting multiple sclerosis. On the contrary, SAMHD1 enhances"/>
 <result pre="solid tumors, such as floxuridine, most often used in the" exact="treatment" post="of colorectal cancer, fluorouracil, used for colon cancer, esophageal"/>
 <result pre="our results might represent the first step of a novel" exact="treatment" post="strategy directed to the activation of SAMHD1 function. In"/>
 <result pre="inhibition of CDK4/6 in combination with endocrine therapies is the" exact="treatment" post="option in hormone receptor-positive/HER2-negative advanced breast cancer. CDK4/6 inhibitors"/>
 <result pre="advanced breast cancer. CDK4/6 inhibitors offer an effective and tolerable" exact="treatment" post="that can be combined with other therapies and thus"/>
 <result pre="enhanced by SAMHD1, which highlights the need for a priori" exact="testing" post="drug efficacy depending on SAMHD1 function. We have applied"/>
 <result pre="efficacy depending on SAMHD1 function. We have applied here a" exact="screening" post="approach based in anti-HIV-1 activity in primary macrophages that"/>
 <result pre="concentrator (Clontech, Mountain View, CA, USA). Viruses were titrated by" exact="infection" post="of TZM cells followed by GFP quantification by flow"/>
 <result pre="Virus Infections MDMs were pretreated with VLP-Vpx for 4h before" exact="infection" post="or left with fresh media as a control. Cells"/>
 <result pre="The anti-HIV activity of the different compounds was determined by" exact="infection" post="of cells in the presence of different concentrations of"/>
 <result pre="(cat. no. 12586-1-AP, Proteintech, Rosemont, IL, USA) and an automated" exact="detection" post="system were utilized. The specificity of the polyclonal antibody"/>
 <result pre="pool of deoxynucleoside triphosphatesNat. Immunol.20121322322810.1038/ni.223622327569 12.HreckaK.HaoC.GierszewskaM.SwansonS.K.Kesik-BrodackaM.SrivastavaS.FlorensL.WashburnM.P.SkowronskiJ.Vpx relieves inhibition of HIV-1" exact="infection" post="of macrophages mediated by the SAMHD1 proteinNature201147465866110.1038/nature1019521720370 13.CribierA.DescoursB.ValadãoA.L.C.LaguetteN.BenkiraneM.Phosphorylation of"/>
 <result pre="damage induced by topoisomerase inhibitors activates SAMHD1 and blocks HIV-1" exact="infection" post="of macrophagesEMBO J.201837506210.15252/embj.20179688029084722 18.MlcochovaP.SutherlandK.A.WattersS.A.BertoliC.de BruinR.A.RehwinkelJ.NeilS.J.LenziG.M.KimB.KhwajaA.et al.A G1-like state allows"/>
 <result pre="A Changing ParadigmNat. Rev. Cancer2009915316610.1038/nrc260219238148 43.PujantellM.FrancoS.Galván-FemeníaI.BadiaR.CastellvíM.Garcia-VidalE.ClotetB.de CidR.TuralC.MartínezM.A.et al.ADAR1 affects HCV" exact="infection" post="by modulating innate immune responseAntivir. Res.201815611612710.1016/j.antiviral.2018.05.01229906476 44.BadiaR.BallanaE.CastellvíM.García-VidalE.PujantellM.ClotetB.PradoJ.G.PuigJ.MartínezM.A.Riveira-MuñozE.et al.CD32 expression"/>
 <result pre="blot showing degradation of SAMHD1 expression in MDMs after Vpx" exact="treatment" post="is also shown. (B) Decreased sensitivity of AZT after"/>
 <result pre="in wild-type (■) or SAMHD1-depleted (Δ) MDMs. Inhibition of HIV" exact="infection" post="was measured as the percentage of GFP+ cells relative"/>
 <result pre="in wild-type (■) or SAMHD1-depleted (Δ) MDM. Inhibition of HIV" exact="infection" post="was measured as the percentage of GFP+ cells relative"/>
 <result pre="in wild-type (■) or SAMHD1-depleted (Δ) MDMs. Inhibition of HIV" exact="infection" post="was measured as the percentage of GFP+ cells relative"/>
 <result pre="in wild-type (■) or SAMHD1-depleted (Δ) MDM. Inhibition of HIV" exact="infection" post="was measured as the percentage of GFP+ cells relative"/>
 <result pre="combination of palbociclib-pemetrexed measured as antiviral activity. Inhibition of HIV" exact="infection" post="with increasing doses of palbociclib and pemetrexed was measured."/>
 <result pre="combination of midostaurin-pemetrexed measured as antiviral activity. Inhibition of HIV" exact="infection" post="with increasing doses of midostaurin and pemetrexed was measured."/>
</results>
